交易中 12-19 09:50:31 美东时间
-0.010
-0.06%
Sotera Health, a sterilization solutions provider, is gaining investor attention due to easing litigation and improving cash flow.
今天 03:30
William Blair analyst Max Smock initiates coverage on Sotera Health (NASDAQ:SHC) with a Outperform rating.
12-18 20:11
Gainers Inspire Veterinary (NASDAQ:IVP) stock increased by 77.5% to $0.22 duri...
11-24 20:05
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
The healthcare sector’s slump had created opportunities for stock-pickers rather than broad sector gains, Goldman Sachs strategist David Kostin said. Healthcare (XLV) has lagged the S&P 500 (SPY) (IVV...
11-11 00:19
Sotera Health Company (Nasdaq: SHC) (the "Company") today announced the launch of a secondary offering (the "Offering") of 30,000,000 shares of its common stock, par value $0.01 per share. All 30,000,000 shares are being
11-07 05:54
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
11-06 09:55
Piper Sandler analyst Jason Bednar maintains Sotera Health (NASDAQ:SHC) with a Neutral and raises the price target from $15 to $17.
11-05 23:59
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Sotera Health第三季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **整体业绩表现:** - 总营收达到3.11亿美元,同比增长9.1%(按固定汇率计算增长8%) - 调整后EBITDA为1.64亿美元,同比增长12.2%(按固定汇率计算增长11.2%) - 净利润为4800万美元,每股收益0.17美元,较去年同期的1700万美元(每股0.06美元)大幅增长 - 调整后每股收益为0.26美元,较去年同期增长0.09美元 **分部门业绩:** - Sterigenics部门营收1.93亿美元,同比增长9.8% - Nor
11-05 12:26
Sotera Health (NASDAQ:SHC) raises FY2025 Adj EPS guidance from $0.75-$0.82 to $0.81-$0.86 vs $0.79 analyst estimate. Affirms FY2025 sales outlook from $1.150 billion-$1.166 billion to $1.150 billion-$1.166 billion vs
11-04 20:04